RAPT THERAPEUTICS, INC.

Profile

Company Names

RAPT THERAPEUTICS, INC.
FLX BIO, INC.

Addresses

561 ECCLES AVENUE, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

(650) 489-9000

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$317,015,836.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2024-12-27 
$149,984,200.00 
$149,984,200.00 
$0.00 
Equity 
4
2022-05-27 
$50,000,000.00 
$50,000,000.00 
$0.00 
 
3
2018-12-18 
$37,103,785.00 
$67,103,784.00 
$29,999,999.00 
Equity 
2
2017-12-15 
$29,927,851.00 
$59,855,714.00 
$29,927,863.00 
Equity 
1
2016-04-21 
$50,000,000.00 
$50,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DIRK 
 
BROCKSTEDT 
EXECUTIVE OFFICER
RAPT THERAPEUTICS, INC.
MICHAEL 
 
GIORDANO 
DIRECTOR
DOING EXPERIMENTS, INC.   |  RAPT THERAPEUTICS, INC.
MICHAEL 
F. 
GIORDANO 
DIRECTOR
FLX BIO, INC.   |  RAPT THERAPEUTICS, INC.
DAVID 
 
GOEDDEL 
DIRECTOR
IGENICA INC   |  NGM BIOPHARMACEUTICALS INC   |  CONSTELLATION PHARMACEUTICALS INC   |  PELOTON THERAPEUTICS, INC.   |  NURIX, INC.   |  NEURONA THERAPEUTICS INC   |  IGENICA BIOTHERAPEUTICS, INC   |  FLX BIO, INC.   |  EXONICS THERAPEUTICS, INC.   |  SURROZEN, INC.   |  A2 BIOTHERAPEUTICS, INC.   |  HEXAGON BIO INC.   |  COLUMN GROUP V, LP   |  COLUMN GROUP OPPORTUNITY III, LP   |  COLUMN GROUP SPV I, LP   |  NGM BIO HOLDINGS, INC.
DAVID 
V. 
GOEDDEL 
DIRECTOR
NGM BIOPHARMACEUTICALS INC   |  FLX BIO, INC.   |  RAPT THERAPEUTICS, INC.
MARY ANN 
V. 
GRAY 
DIRECTOR
RAPT THERAPEUTICS, INC.
ERIC 
 
HALL 
EXECUTIVE OFFICER
SO GOOD BRAND, INC.   |  SITE 10.01, INC.   |  RAPT THERAPEUTICS, INC.   |  CRESCENT CREDIT OPPORTUNITIES FUND (CAYMAN), L.P.   |  CRESCENT CREDIT OPPORTUNITIES FUND AIF SCSP   |  CRESCENT CREDIT OPPORTUNITIES FUND, L.P.
REKHA 
 
HEMRAJANI 
EXECUTIVE OFFICER
3-V BIOSCIENCES, INC.   |  FLX BIO, INC.
WILLIAM 
 
HO 
EXECUTIVE OFFICER
ALEPHPOINT CAPITAL, LP   |  INCYSUS THERAPEUTICS, INC.   |  RAPT THERAPEUTICS, INC.   |  IN8BIO, INC.
PAUL 
 
KASSNER 
EXECUTIVE OFFICER
RAPT THERAPEUTICS, INC.
LINDA 
 
KOZICK 
DIRECTOR
FLX BIO, INC.   |  RAPT THERAPEUTICS, INC.
TIM 
 
LIN 
EXECUTIVE OFFICER
FLX BIO, INC.
LORI 
 
LYONS-WILLIAMS 
DIRECTOR
DERMIRA, INC.   |  RAPT THERAPEUTICS, INC.
WILLIAM 
J. 
RIEFLIN 
DIRECTOR
XENOPORT INC   |  NGM BIOPHARMACEUTICALS INC   |  FLX BIO, INC.   |  RAPT THERAPEUTICS, INC.   |  NGM BIO HOLDINGS, INC.
WENDYE 
 
ROBBINS 
DIRECTOR
LIMERICK BIOPHARMA INC   |  THERACLONE SCIENCES, INC.   |  BLADE THERAPEUTICS, INC.   |  RAPT THERAPEUTICS, INC.
BETH 
 
SEIDENBERG 
DIRECTOR
3-V BIOSCIENCES, INC.   |  HX DIAGNOSTICS INC   |  IPIERIAN, INC.   |  REDBRICK HEALTH CORP   |  TESARO, INC.   |  AUXOGYN INC   |  PRACTICE FUSION INC   |  SANTA MARIA BIOTHERAPEUTICS, INC.   |  PINTA BIOTHERAPEUTICS, INC.   |  NINA BIOTHERAPEUTICS, INC.   |  BREATHE TECHNOLOGIES INC   |  AUXOGYN, INC.   |  FLEXUS BIOSCIENCES, INC.   |  LIVONGO HEALTH, INC.   |  PROGYNY, INC.   |  CELL DESIGN LABS, INC.   |  FLX BIO, INC.   |  HIXME INSURANCE SOLUTIONS, INC.   |  KINSA INC.   |  BREATHE ACQUISITION CORP.   |  BREATHE TECHNOLOGIES, INC.   |  WESTLAKE BIOPARTNERS FUND I, L.P.   |  RAPT THERAPEUTICS, INC.   |  TMUNITY THERAPEUTICS, INC.   |  SAGIMET BIOSCIENCES INC.   |  VERA THERAPEUTICS, INC.   |  WESTLAKE BIOPARTNERS OPPORTUNITY FUND I, L.P.   |  ARSENAL BIOSCIENCES, INC.   |  LATIGO BIOTHERAPEUTICS, INC.   |  STAR THERAPEUTICS LLC
BRIAN 
 
WONG 
EXECUTIVE OFFICER, DIRECTOR
KIIP, INC.   |  FLX BIO, INC.   |  RAPT THERAPEUTICS, INC.   |  ASCII VENTURES FUND I LP
DAVID 
 
WUSTROW 
EXECUTIVE OFFICER
RAPT THERAPEUTICS, INC.
RODNEY 
 
YOUNG 
EXECUTIVE OFFICER
CELLERANT THERAPEUTICS INC   |  RAPT THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-01-03
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-12-27 
2022-06-03
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2022-05-27 
2019-06-20
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-12-18 
2019-01-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-18 
2018-01-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-15 
2016-05-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LEERINK PARTNERS LLC
39011